Milestone Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q2 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2024 | 3 | -$0.18 | -$0.15 | -$0.16 |
| Q1 2025 | 2 | -$0.27 | -$0.14 | -$0.20 |
| Q2 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q3 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q4 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
Milestone Pharmaceuticals Inc. Earnings Date And Information
Milestone Pharmaceuticals Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.14 earnings per share for the quarter, topping analysts' consensus estimates of $-0.19 by $0.05. The company had revenue of 0 for the quarter and had revenue of 1.00 M for the year. Milestone Pharmaceuticals Inc. has generated $-1 earnings per share over the last year ($-1.39 diluted earnings per share) and currently has a price-to-earnings ratio of -3.38. Milestone Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based on prior year's report dates.
Milestone Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.14 | $0 | $0 | ||
| 08/08/2024 | Q2 2024 | -$0.19 | -$0.14 | 0.05 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$0.26 | -$0.21 | 0.05 | $0 | |
| 04/29/2024 | Q4 2023 | -$0.41 | $-868,002 | |||
| 11/13/2023 | Q3 2023 | -$0.38 | -$0.35 | 0.03 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.39 | -$0.37 | 0.02 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.38 | -$0.34 | 0.04 | $1.00 M | |
| 03/29/2023 | Q4 2022 | -$0.35 | $0.43 | 0.78 | $3.50 M | |
| 11/10/2022 | Q3 2022 | -$0.41 | -$0.33 | 0.08 | $1.50 M | |
| 08/10/2022 | Q2 2022 | -$0.36 | -$0.39 | -0.03 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.39 | -$0.33 | 0.06 | $0 | |
| 03/24/2022 | Q4 2021 | -$0.36 | -$0.40 | -0.04 | $15.00 M | |
| 11/12/2021 | Q3 2021 | -$0.38 | -$0.34 | 0.04 | $0 | |
| 08/11/2021 | Q2 2021 | -$0.26 | $0.02 | 0.28 | $5.00 M | $15.00 M |
| 05/17/2021 | Q1 2021 | -$0.33 | -$0.30 | 0.03 | $0 | |
| 03/29/2021 | Q4 2020 | -$0.41 | -$0.29 | 0.12 | $57.44 M | |
| 11/13/2020 | Q3 2020 | -$0.49 | -$0.40 | 0.09 | $0 | |
| 08/12/2020 | Q2 2020 | -$0.47 | -$0.53 | -0.06 | $0 | |
| 05/14/2020 | Q1 2020 | -$0.74 | -$0.67 | 0.07 | $0 | |
| 03/06/2020 | Q4 2019 | -$0.52 | -$0.75 | -0.23 | $0 |
Milestone Pharmaceuticals Inc. Earnings: Frequently Asked Questions
-
When is Milestone Pharmaceuticals Inc.'s earnings date?
Milestone Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates.
-
Did Milestone Pharmaceuticals Inc. beat their earnings estimates last quarter?
In the previous quarter, Milestone Pharmaceuticals Inc. (:MIST) reported $-0.14 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.05.
-
How can I listen to Milestone Pharmaceuticals Inc.'s earnings conference call?
The conference call for Milestone Pharmaceuticals Inc.'s latest earnings report can be listened to online.
-
How can I read Milestone Pharmaceuticals Inc.'s conference call transcript?
The conference call transcript for Milestone Pharmaceuticals Inc.'s latest earnings report can be read online.
-
How much revenue does Milestone Pharmaceuticals Inc. generate each year?
Milestone Pharmaceuticals Inc. (:MIST) has a recorded annual revenue of $1.00 M.
-
How much profit does Milestone Pharmaceuticals Inc. generate each year?
Milestone Pharmaceuticals Inc. (:MIST) has a recorded net income of $1.00 M. Milestone Pharmaceuticals Inc. has generated $-1.39 earnings per share over the last four quarters.
-
What is Milestone Pharmaceuticals Inc.'s price-to-earnings ratio?
Milestone Pharmaceuticals Inc. (:MIST) has a price-to-earnings ratio of -3.38 and price/earnings-to-growth ratio is -0.18.
